OSMRβ mutants enhance basal keratinocyte differentiation via inactivation of the STAT5/ KLF7 axis in PLCA patients

References

[1] Arita K, South AP, Hans-Filho G, Sakuma TH, Lai-Cheong J, Clements S, Odashiro M, Odashiro DN, Hans-Neto G, Hans NR(2008) Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis. Am J Hum Genet 82:73–80

[2] Chang YT, Lin CH, Lee CT, Lin MW, Liu LY, Chen CC, Lee DD, Liu HN, Tsai SF, Matsuura I (2014) Detection of common mutations in sporadic primary localized cutaneous amyloidosis by DNA mass spectrometry. Br J Dermatol 170:974–976

[3] Gertz J, Savic D, Varley KE, Partridge EC, Safi A, Jain P, Cooper GM, Reddy TE, Crawford GE, Myers RM (2013) Distinct properties of cell-type-specific and shared transcription factor binding sites. Mol Cell 52:25–36

[4] Katayama C, Hayashida Y, Sugiyama S, Shiohara T, Aoyama Y (2019) Postherpetic hypohidrosis-related isotopic response associated with lichen planus and lichen amyloidosis. Eur J Dermatol 29:233–234

[5] Kubin T, Poling J, Kostin S, Gajawada P, Hein S, Rees W, Wietelmann A, Tanaka M, Lorchner H, Schimanski S(2011) Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling. Cell Stem Cell 9:420–432

[6] Lu P, Wu FF, Rong ZL, Fang C, Deng CC, Bin LH, Yang B (2019) Clinical and genetic features of Chinese patients with lichen and macular primary localized cutaneous amyloidosis. Clin Exp Dermatol 44:e110–e117

[7] Sampath SC, Sampath SC, Ho ATV, Corbel SY, Millstone JD, Lamb J, Walker J, Kinzel B, Schmedt C, Blau HM (2018) Induction of muscle stem cell quiescence by the secreted niche factor Oncostatin M. Nat Commun 9:1531

[8] Shiao YM, Chung HJ, Chen CC, Chiang KN, Chang YT, Lee DD, Lin MW, Tsai SF, Matsuura I(2013) MCP-1 as an effector of IL-31 signaling in familial primary cutaneous amyloidosis. J Invest Dermatol 133:1375–1378

[9] Tanaka A, Arita K, Lai-Cheong JE, Palisson F, Hide M, McGrath JA (2009) New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis. Br J Dermatol 161:1217–1224

[10] Tey HL, Cao T, Nattkemper LA, Tan VW, Pramono ZA, Yosipovitch G(2016) Pathophysiology of pruritus in primary localized cutaneous amyloidosis. Br J Dermatol 174:1345–1350

[11] Villarino AV, Sciume G, Davis FP, Iwata S, Zitti B, Robinson GW, Hennighausen L, Kanno Y, O’Shea JJ (2017) Subset- and tissuedefined STAT5 thresholds control homeostasis and function of innate lymphoid cells. J Exp Med 214:2999–3014

[12] Wali A, Liu L, Takeichi T, Jelani M, Rahman OU, Heng YK, Thng S, Lee J, Akiyama M, McGrath JA(2015) Familial primary localized cutaneous amyloidosis results from either dominant or recessive mutations in OSMR. Acta Derm Venereol 95:1005–1007

[13] Wang X, Shen QW, Wang J, Zhang Z, Feng F, Chen T, Zhang Y, Wei H, Li Z, Wang X(2016) KLF7 Regulates Satellite Cell Quiescence in Response to Extracellular Signaling. Stem Cells 34:1310–1320

[14] Wang ECE, Dai Z, Ferrante AW, Drake CG, Christiano AM (2019) A Subset of TREM2(+) Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth. Cell Stem Cell 24(654–669):e656

[15] Yang CF, Lin SP, Chiang CP, Wu YH, H’Ng WS, Chang CP, Chen YT, Wu JY (2018) Loss of GPNMB Causes Autosomal-Recessive Amyloidosis Cutis Dyschromica in Humans. Am J Hum Genet 102:219–232

RIGHTS & PERMISSIONS

The Author(s)